OSM Enhances Angiogenesis and Improves Cardiac Function after Myocardial Infarction

BioMed Research International

Volumn 2015, Issue , 2015, Pages

  Zhang, Xiaotian ^a   Zhu, Di ^a   Wei, Liping ^b   Zhao, Zhijing ^a   Qi, Xin ^b   Li, Zongjin ^c   Sun, Dongdong ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b TIANJIN UNION MEDICAL CENTER   (China)

^c NANKAI UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ACTIN; CASPASE 3; COLLAGEN TYPE 1; COLLAGEN TYPE 3; FIBROBLAST GROWTH FACTOR 2; MESSENGER RNA; ONCOSTATIN M; PROTEIN KINASE B; VASCULOTROPIN; VASCULAR ENDOTHELIAL GROWTH FACTOR A, MOUSE; VASCULOTROPIN A;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CAPILLARY DENSITY; CONTROLLED STUDY; HEART FUNCTION; HEART HYPERTROPHY; HEART INFARCTION; HEART MUSCLE FIBROSIS; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HEART WEIGHT; LUNG CONGESTION; LUNG WEIGHT; MOUSE; NONHUMAN; UPREGULATION; ANIMAL; CARDIAC MUSCLE; FIBROSIS; GENETICS; HEART VENTRICLE REMODELING; HUMAN; KNOCKOUT MOUSE; PATHOLOGY; PATHOPHYSIOLOGY;

MUS;

ANIMALS; APOPTOSIS; FIBROSIS; HUMANS; MICE; MICE, KNOCKOUT; MYOCARDIAL INFARCTION; MYOCARDIUM; NEOVASCULARIZATION, PHYSIOLOGIC; ONCOSTATIN M; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VENTRICULAR REMODELING;

EID: 84934912042     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2015/317905     Document Type: Article

References (24)

1. A. S. Go, D. Mozaffarian, V. L. Roger et al., "Heart Disease and Stroke Statistics-2014 update: a report from the American Heart Association", Circulation, vol. 129, no. 3, pp. e28-e292, 2014.
2. A. S. Go, D. Mozaffarian, V. L. Roger et al., "Heart disease and stroke statistics-2013 update: a report from the American Heart Association", Circulation, vol. 127, pp. e6-e245, 2013.
3. B. Messner, J. Kern, D. Wiedemann et al., "5-Methoxyleoligin, a lignan from Edelweiss, stimulates CYP26B1-dependent angiogenesis in vitro and induces arteriogenesis in infarcted rat hearts in vivo", PLoS ONE, vol. 8, no. 3, Article ID e58342, 2013.
4. K. Albrecht-Schgoer, W. Schgoer, J. Holfeld et al., "The angiogenic factor secretoneurin induces coronary angiogenesis in a model of myocardial infarction by stimulation of vascular endothelial growth factor signaling in endothelial cells", Circulation, vol. 126, no. 21, pp. 2491-2501, 2012.
5. M. Siragusa, R. Katare, M. Meloni et al., "Involvement of phosphoinositide 3-kinase γ in angiogenesis and healing of experimental myocardial infarction in mice", Circulation Research, vol. 106, no. 4, pp. 757-768, 2010.
6. A. Bronckaers, P. Hilkens, W. Martens et al., "Mesenchymal stem/stromal cells as a pharmacological and therapeutic approach to accelerate angiogenesis", Pharmacology and Therapeutics, vol. 143, pp. 181-196, 2014.
7. P. J. Hohensinner, C. Kaun, K. Rychli et al., "The inflammatory mediator oncostatin M induces stromal derived factor-1 in human adult cardiac cells", The FASEB Journal, vol. 23, no. 3, pp. 774-782, 2009.
8. M. Gwechenberger, D. Moertl, R. Pacher, and M. Huelsmann, "Oncostatin-M in myocardial ischemia/reperfusion injury may regulate tissue repair", Croatian Medical Journal, vol. 45, no. 2, pp. 149-157, 2004.
9. J. Pöling, P. Gajawada, M. Richter et al., "Therapeutic targeting of the oncostatin M receptor-β prevents inflammatory heart failure", Basic Research in Cardiology, vol. 109, no. 1, article 396, 2014.
10. S. L. Fossey, M. D. Bear, W. C. Kisseberth, M. Pennell, and C. A. London, "Oncostatin M promotes STAT3 activation, VEGF production, and invasion in osteosarcoma cell lines", BMC Cancer, vol. 11, article 125, 2011.
11. E. S. Wijelath, B. Carlsen, T. Cole, J. Chen, S. Kothari, and W. P. Hammond, "Oncostatin M induces basic fibroblast growth factor expression in endothelial cells and promotes endothelial cell proliferation, migration and spindle morphology", Journal of Cell Science, vol. 110, part 7, pp. 871-879, 1997.
12. M. Vasse, J. Pourtau, V. Trochon et al., "Oncostatin M induces angiogenesis in vitro and in vivo", Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 19, no. 8, pp. 1835-1842, 1999.
13. K. Rychli, C. Kaun, P. J. Hohensinner et al., "The inflammatory mediator oncostatin M induces angiopoietin 2 expression in endothelial cells in vitro and in vivo", Journal of Thrombosis and Haemostasis, vol. 8, no. 3, pp. 596-604, 2010.
14. S. Araki, Y. Izumiya, S. Hanatani et al., "Akt1-mediated skeletal muscle growth attenuates cardiac dysfunction and remodeling after experimental myocardial infarction", Circulation: Heart Failure, vol. 5, no. 1, pp. 116-125, 2012.
15. C.-N. Hao, J.-J. Huang, Y.-Q. Shi et al., "Pulsed electromagnetic field improves cardiac function in response to myocardial infarction", The American Journal of Translational Research, vol. 6, no. 3, pp. 281-290, 2014.
16. R. S. Adluri, M. Thirunavukkarasu, L. Zhan et al., "Glutaredoxin-1 overexpression enhances neovascularization and diminishes ventricular remodeling in chronic myocardial infarction", PLoS ONE, vol. 7, no. 3, p. e34790, 2012.
17. C. Cochain, K. M. Channon, and J.-S. Silvestre, "Angiogenesis in the infarcted myocardium", Antioxidants & Redox Signaling, vol. 18, no. 9, pp. 1100-1113, 2013.
18. R. S. Adluri, M. Thirunavukkarasu, L. Zhan et al., "Thioredoxin 1 enhances neovascularization and reduces ventricular remodeling during chronic myocardial infarction: a study using thioredoxin 1 transgenic mice", Journal of Molecular and Cellular Cardiology, vol. 50, no. 1, pp. 239-247, 2011.
19. D. Ribatti and E. Crivellato, "'Sprouting angiogenesis', a reappraisal", Developmental Biology, vol. 372, no. 2, pp. 157-165, 2012.
20. M. Murakami, "Signaling required for blood vessel maintenance: molecular basis and pathological manifestations", International Journal of Vascular Medicine, vol. 2012, Article ID 293641, 15 pages, 2012.
21. R. Cao, A. Eriksson, H. Kubo, K. Alitalo, Y. Cao, and J. Thyberg, "Comparative evaluation of FGF-2-, VEGF-A-, and VEGF-C-induced angiogenesis, lymphangiogenesis, vascular fenestrations, and permeability", Circulation Research, vol. 94, no. 5, pp. 664-670, 2004.
22. T. Zhao, W. Zhao, Y. Chen, R. A. Ahokas, and Y. Sun, "Vascular endothelial growth factor (VEGF)-A: role on cardiac angiogenesis following myocardial infarction", Microvascular Research, vol. 80, no. 2, pp. 188-194, 2010.
23. T. Kubin, J. Pöling, S. Kostin et al., "Oncostatin M is a major mediator of cardiomyocyte dedifferentiation and remodeling", Cell Stem Cell, vol. 9, no. 5, pp. 420-432, 2011.
24. F. Beigel, M. Friedrich, C. Probst et al., "Oncostatin M mediates STAT3-dependent intestinal epithelial restitution via increased cell proliferation, decreased apoptosis and upregulation of SERPIN family members", PLoS ONE, vol. 9, no. 4, Article ID e93498, 2014.